ArticleAfrican journal of infectious diseases2024
ASSESSING THE KNOWLEDGE OF SMALLPOX AND MONKEYPOX VIRUS AMONG THE UNIVERSITY OF TLEMCEN MEMBERS IN THE WAKE OF COVID-19: A 2023 CROSS-SECTIONAL STUDY.
Article in African journal of infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: A recently-surfaced virus called Monkeypox virus (MPXV) has gained widespread attention as it dominates the news, creating a sense of panic among people due to the potential threat it poses to their health. Materials and Methods: To evaluate knowledge about this virus and its disease, and to raise consciousness among the members of the Faculty of Natural and Life Sciences and Earth and Universe Sciences at the University of Tlemcen, we launched an online web-based survey for a twenty days' period that contained sociodemographic and perceptiveness questions about the emergent virus, its disease, and vaccination. Results: Our findings showed that the majority of the respondents of our study have a satisfactory level of knowledge about this emerging virus and its disease. Moreover, most participants showed a positive attitude towards the vaccine, considering it the best preventive means to fight against Monkeypox disease. Conclusion: Although the MPXV may not become a pandemic, but knowing the various ways that contribute to its spread is essential to avoid any possibility of a new one, especially in Algeria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.